Showing 1 - 5 results of 5 for search '"hba<sub>1c</sub>"', query time: 0.38s Refine Results
  1. 1
    Results of a clinical trial of the efficacy and safety of vildagliptin and metformin fixed combination in real clinical practice in Russia (MASTER study)

    Results of a clinical trial of the efficacy and safety of vildagliptin and metformin fixed combination in real clinical practice in Russia (MASTER study) by N. A. Demidov, M. B. Antsiferov, A. V. Zilov

    Published 2021-02-01
    Subjects:
    Get full text
    Article
  2. 2
    The comparison of two measuring methods of Glycolated hemoglobin in fasting and non-fasting conditions

    The comparison of two measuring methods of Glycolated hemoglobin in fasting and non-fasting conditions by H Alaoddolei, J Vahab Zanjani, F Sadighian

    Published 2000-10-01
    Subjects:
    Get full text
    Article
  3. 3
    High level of glycated hemoglobin (HbA<sub>1c</sub>) in patients with COVID-19 is a marker of the severity of the infection but not an indicator of previous diabetes mellitus

    High level of glycated hemoglobin (HbA<sub>1c</sub>) in patients with COVID-19 is a marker of the severity of the infection but not an indicator of previous diabetes mellitus by M. V. Shestakova, I. V. Kononenko, Z. A. Kalmykova, A. V. Zheleznyakova, N. G. Mokrysheva

    Published 2021-02-01
    Subjects:
    Get full text
    Article
  4. 4
    Predictors of success and failure in achieving glycemic control targets in patients with type 2 diabetes on basal insulin: review of the real-world evidence studies

    Predictors of success and failure in achieving glycemic control targets in patients with type 2 diabetes on basal insulin: review of the real-world evidence studies by V. V. Klimontov

    Published 2023-01-01
    Subjects:
    Get full text
    Article
  5. 5
    Early intensification of therapy for type 2 diabetes mellitus and achievement of the target level of glycohemoglobin HbA<sub>1c</sub> are necessary factors to reduce the risk of micro- and macrovascular complications

    Early intensification of therapy for type 2 diabetes mellitus and achievement of the target level of glycohemoglobin HbA<sub>1c</sub> are necessary factors to reduce the risk of mi... by M. S. Shamkhalova, O. Y. Sukhareva

    Published 2023-08-01
    Subjects:
    Get full text
    Article

Search Tools: